Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

non-small cell lung cancer

  • You have access
    Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study
    ONDREJ FIALA, JAN BAXA, MARTIN SVATON, LUCIE BENESOVA, RENATA PTACKOVA, TEREZA HALKOVA, MAREK MINARIK, PETR HOSEK, MARCELA BURESOVA, JINDRICH FINEK, JIRI FERDA and MILOS PESEK
    Cancer Genomics & Proteomics March 2022, 19 (2) 270-281; DOI: https://doi.org/10.21873/cgp.20319
  • Open Access
    Targeted Sequencing of Circulating Cell Free DNA Can Be Used to Monitor Therapeutic Efficacy of Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients
    CHIUAN-CHIAN CHIOU, CHIH-LIANG WANG, JI-DUNG LUO, CHIEN-YING LIU, HOW-WEN KO and CHENG-TA YANG
    Cancer Genomics & Proteomics July 2020, 17 (4) 417-423; DOI: https://doi.org/10.21873/cgp.20200
  • Open Access
    Transcriptomic Analysis in Liquid Biopsy Identifies Circulating PCTAIRE-1 mRNA as a Biomarker in NSCLC
    JOHN WEN-CHENG CHANG, CHUN-LIANG SHIH, CHIH-LIANG WANG, JI-DUNG LUO, CHIH-WEI WANG, JIA-JUAN HSIEH, CHIA-JUNG YU and CHIUAN-CHIAN CHIOU
    Cancer Genomics & Proteomics January 2020, 17 (1) 91-100; DOI: https://doi.org/10.21873/cgp.20170
  • Open Access
    The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience
    JAVIER TORRALVO, ALEX FRIEDLAENDER, VERANE ACHARD and ALFREDO ADDEO
    Cancer Genomics & Proteomics November 2019, 16 (6) 577-582; DOI: https://doi.org/10.21873/cgp.20160
  • Open Access
    Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients
    CHERYLLE GOEBEL, CHRISTOPHER L. LOUDEN, ROBERT MCKENNA, OSITA ONUGHA, ANDREW WACHTEL and THOMAS LONG
    Cancer Genomics & Proteomics July 2019, 16 (4) 229-244; DOI: https://doi.org/10.21873/cgp.20128
  • Open Access
    Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR Mutation
    KAZUTOSHI ISOBE, ATSUSHI KAKIMOTO, TETSUO MIKAMI, KYOHEI KABURAKI, HIROSHI KOBAYASHI, TAKAHIRO YOSHIZAWA, TAKASHI MAKINO, HAJIME OTSUKA, GO SANO, KEISHI SUGINO, SUSUMU SAKAMOTO, YUJIRO TAKAI, NAOBUMI TOCHIGI, AKIRA IYODA and SAKAE HOMMA
    Cancer Genomics & Proteomics November 2016, 13 (6) 475-482;
  • Open Access
    Gene-expression Profiling in Non-small Cell Lung Cancer with Invasion of Mediastinal Lymph Nodes for Prognosis Evaluation
    MADALINA GRIGOROIU, REBECCA TAGETT, SORIN DRAGHICI, SIMONA DIMA, ANCA NASTASE, RALUCA FLOREA, ANDREI SOROP, VERONICA ILIE, NICOLAE BACALBASA, VALERIA TICA, VIKTORIA LASZLO, AUDREY MANSUET-LUPO, DIANNE DAMOTTE, WALTER KLEPETKO, IRINEL POPESCU and JEAN FRANCOIS REGNARD
    Cancer Genomics & Proteomics September 2015, 12 (5) 231-242;
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire